Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report

Author(s):  Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don

Issue:  Jul/Aug 2018 - Volume 22, Number 4
View All Articles in Issue

Page(s):  270-278

Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 1
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 2
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 3
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 4
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 5
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 6
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 7
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 8
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Page 9

Download in electronic PDF format for $75

Abstract:  The ancient autoimmune skin condition psoriasis is still ubiquitous worldwide, produces the same, often-intolerable effects noted in its earliest recorded descriptions, and remains without cure. Management options designed to resolve the itchy, scaly, weeping, erythematous, and often widespread lesions of that disorder are now available, but they vary in efficacy, most are associated with the development of severe adverse effects, and many are prohibitively expensive. In this article, we describe the successful use of a compounded formulation of oral low-dose naltrexone to manage guttate psoriasis in a 75-year-old white male patient. That therapy produced only 1 adverse effect (dry skin near the lesions on the patient’s arms and legs) and was relatively inexpensive. The formulation for that preparation and comments from the patient, the pharmacist who suggested its use, the prescriber, and the compounder who prepared it are included. Many clinicians are unaware of the benefits of compounded low-dose naltrexone in treating autoimmune diseases. We hope that this case report will encourage compounding pharmacists to consider and suggest it as an alternative therapy for patients who cannot tolerate or afford manufactured medications to treat psoriasis.

Related Keywords: autoimmune disorders, skin disorders, guttate psoriasis, inflammation, case report, low-dose naltrexone, formulation, naltrexone hydrochloride, drug costs, adverse effects

Related Categories: DERMATOLOGY, FORMULATIONS, CASE REPORTS, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George
, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018
Pg. 270-278

Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin
, Carvalho Maria, Banov Fabiana
Nov/Dec 2023
Pg. 468-473

Low-dose Naltrexone Therapy for Psoriasis
Weinstock Leonard B
, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2020
Pg. 94-96

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer
, Weinstock Leonard B, Thomas Erin
Mar/Apr 2010
Pg. 171-173

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M
, Collin Michael
May/Jun 2016
Pg. 197-201

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat
, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017
Pg. 205-211

Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Harris Kylie
, Wright Edward
Nov/Dec 2021
Pg. 482-485

The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia
Cote Brianna
, Ross Bethany, Fortner Jeff, Rao Deepa
May/Jun 2018
Pg. 252-256

Compounding Naltrexone for the Treatment of Autism
Wynn Tom
, Brunetti Sarah
Jul/Aug 2009
Pg. 296-299

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Earlywine Kerry
, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jan/Feb 2023
Pg. 6-10

Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral
, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022
Pg. 6-8

Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
Jan/Feb 2007
Pg. 26-27

Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos
, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011
Pg. 27-31

Low-dose Pilocarpine Spray to Treat Xerostomia
Zur Eyal
Mar/Apr 2020
Pg. 104-108

Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert
, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008
Pg. 498-504

Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Mason Dave
Jan/Feb 1999
Pg. 34-35

Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
Jan/Feb 2016
Pg. 6-10

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Return to Top